发明名称 Method of diagnosing or assessing risk for Parkinson's disease or Alzheimer's disease using TCR clonality
摘要 Changes in adaptive immune system were identified and correlated as a predictor of A&bgr;40 and A&bgr;42 and AD progression. T-cell, B-cell, TCR and BCR profiles were used to correlate clinical progression of AD. The CDR3 region was spectratyped, showing the clonality of the CDR3 region. This intrafamily gene fragment length profile was compared to age-matched controls, thereby indicating the existence of a neurodegenerative disease. The novel method is useful in diagnosing neurodegenerative disease, like Parkinson's disease, HIV-associated Dementia, or Alzheimer's disease. Moreover, this permits the clinical identification of patients at a very early stage of AD and/or monitoring the potential benefits of disease modifying therapeutics.
申请公布号 US8383347(B1) 申请公布日期 2013.02.26
申请号 US20100772728 申请日期 2010.05.03
申请人 UNIVERSITY OF SOUTH FLORIDA;CAO CHUANHAI;LIN XIAOYANG;POTTER HUNTINGTON 发明人 CAO CHUANHAI;LIN XIAOYANG;POTTER HUNTINGTON
分类号 C12Q1/68;C12P19/34 主分类号 C12Q1/68
代理机构 代理人
主权项
地址